Dr.ย Bhumsukย Keam
MD, MS, PhD
Clinical Professor, Medical Oncology
corporate_fareSeoul National University Hospital, Seoul
Bhumsuk Keam
MD, MS, PhD
Prof. Bhumsuk Keam is a Clinical Professor in the Department of Internal Medicine at Seoul National University Hospital (SNUH), one of South Korea's foremost academic medical centres. He practises in the Division of Haematology and Medical Oncology, with verified clinical specialties in head and neck cancer, lung cancer, esophageal cancer, clinical trials, and personalised cancer treatment.
Prof. Keam's entire academic and clinical career has been rooted at Seoul National University and SNUH, where he progressed from internship and residency through fellowship to his current professorship. With more than two decades of oncology experience, his work spans systemic therapy, biomarker-guided treatment, immune checkpoint inhibition, targeted therapy, and translational research. His publication record exceeds 300 research outputs in Seoul National University's academic database, with recognised fingerprints in head and neck squamous cell carcinoma, non-small cell lung cancer, EGFR-targeted therapy, and PD-1/PD-L1 immunotherapy. He has served on the ESMO Head and Neck Cancer faculty and is an active member of ASCO, ESMO, IASLC, and the Korean Cancer Study Group.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Keam at Seoul National University Hospital.
Why Consider Prof. Bhumsuk Keam?
Prof. Keam combines more than two decades of academic oncology with an active research programme at one of Asia's leading cancer centres. Patients with head and neck, lung, or esophageal cancer benefit from his expertise in both standard systemic therapy and emerging immunotherapy approaches.
Areas of Specialisation
Prof. Keam's clinical practice covers the full spectrum of systemic oncology for solid tumours of the head and neck, thoracic, and upper gastrointestinal tract.
Prof. Keam's specialisation is rooted in medical oncology for solid tumours, with a particular emphasis on head and neck squamous cell carcinoma, non-small cell lung cancer, and esophageal cancer. His treatment approach integrates chemotherapy, immunotherapy, targeted therapy, and clinical trial access where appropriate.
Head & Neck Cancer
Systemic management of locally advanced, recurrent, and metastatic head and neck squamous cell carcinoma including immunotherapy-based regimens.
- arrow_rightInduction chemotherapy for locally advanced head and neck squamous cell carcinoma
- arrow_rightCisplatin-based and combination protocols tailored to disease stage
- arrow_rightMultimodal treatment planning in collaboration with radiation oncology and surgery
- arrow_rightPD-1 inhibitors including pembrolizumab for recurrent or metastatic disease
- arrow_rightBiomarker and PD-L1 expression assessment for treatment eligibility
- arrow_rightClinical trial participation in checkpoint inhibitor research
Lung Cancer
Medical oncology for non-small cell lung cancer with a focus on EGFR-targeted therapy and systemic treatment planning.
- arrow_rightTyrosine kinase inhibitor selection based on mutation profiling
- arrow_rightMonitoring and management of treatment response and resistance
- arrow_rightResearch involvement in ROS1-rearranged NSCLC and second-line strategies
- arrow_rightChemotherapy and immunotherapy protocols for advanced NSCLC
- arrow_rightPersonalised treatment planning based on pathology, staging, and biomarkers
Esophageal Cancer & Upper GI Oncology
Medical oncology consultation for esophageal and upper gastrointestinal malignancies.
- arrow_rightChemotherapy and targeted approaches for esophageal carcinoma
- arrow_rightMultidisciplinary treatment planning alongside surgical and radiation oncology teams
Procedures Performed
Clinical services and treatment approaches at Seoul National University Hospital
Prof. Keam provides comprehensive medical oncology services for patients with head and neck, lung, and esophageal cancers, including chemotherapy, immunotherapy, targeted therapy, clinical trial assessment, and personalised treatment planning.
Medical Oncology Consultation
Medical OncologyComprehensive assessment and systemic treatment planning for solid tumours of the head and neck, thoracic, and upper gastrointestinal tract.
Immunotherapy
Targeted TherapyImmune checkpoint inhibitor therapy for eligible patients with advanced head and neck and lung cancer.
Targeted Therapy
Targeted TherapyMolecularly guided therapy for patients with actionable genomic alterations in lung and other solid tumours.
Clinical Trial Access
MultidisciplinaryAssessment for clinical trial eligibility across solid tumour oncology programmes at SNUH.
Second Opinion
Second OpinionExpert second-opinion review for patients with head and neck, lung, or esophageal cancer diagnoses and treatment plans.
Research & Publications
Peer-reviewed contributions in medical oncology at Seoul National University
Prof. Keam has an extensive academic research profile. Seoul National University's research portal lists more than 300 outputs associated with his academic record, spanning head and neck squamous cell carcinoma, non-small cell lung cancer, EGFR-targeted therapy, PD-1/PD-L1 immunotherapy, neoadjuvant chemotherapy, and tumour microenvironment research.
Prof. Keam's full publication list is available through Seoul National University's research portal. A more detailed list can be requested on enquiry.
Education & Training
Prof. Keam completed his entire medical education at Seoul National University, earning a medical degree, master's, and PhD from its College of Medicine. His clinical training was conducted exclusively at Seoul National University Hospital.
Clinical Experience
Prof. Keam's clinical career spans more than two decades at Seoul National University Hospital, where he progressed from internship through residency, fellowship, and successive faculty ranks to his current position as Clinical Professor. He has been based in the Division of Haematology and Medical Oncology throughout his academic career.
Languages & International
Prof. Keam consults in the following languages.
CancerFax can coordinate professional medical interpreter support to facilitate consultations for international patients at Seoul National University Hospital.
CancerFax can coordinate professional medical interpreter support for international patients consulting in English or other languages.
How CancerFax Helps You Access Dr. Bhumsuk Keam
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Bhumsuk Keam's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Bhumsuk Keam's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Bhumsuk Keam before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Bhumsuk Keam's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Bhumsuk Keam's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Bhumsuk Keam's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Bhumsuk Keam
Prof. Keam's verified clinical specialties include head and neck cancer, lung cancer, and esophageal cancer. He also has expertise in clinical trials and personalised cancer treatment. His research is particularly strong in head and neck squamous cell carcinoma and non-small cell lung cancer.
Prof. Keam is a Clinical Professor in the Department of Internal Medicine at Seoul National University Hospital (SNUH) in Seoul, South Korea. He practises in the Division of Haematology and Medical Oncology and the Medical Oncology Center.
Seoul National University Hospital provides dedicated international patient support channels for foreign patients. CancerFax can coordinate medical-report preparation, case submission, and consultation support for international patients seeking an opinion from Prof. Keam, subject to hospital availability and case acceptance.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare a structured case summary, and coordinate the next steps with Seoul National University Hospital, subject to appointment availability and clinical suitability.
Yes. A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging studies, treatment history, and relevant laboratory results. The consultation format and availability are subject to the hospital's process for international cases.
Prof. Keam's verified clinical and research areas include chemotherapy (including induction chemotherapy for head and neck cancer), immunotherapy with PD-1/PD-L1 checkpoint inhibitors such as pembrolizumab, EGFR-targeted therapy for lung cancer, biomarker-driven personalised treatment planning, and clinical trial-based cancer care.
Yes. Seoul National University's research portal lists more than 300 outputs associated with Prof. Keam. His published work includes a Phase II study of induction chemotherapy in locally advanced head and neck cancer and a KEYNOTE-012 expansion cohort study on pembrolizumab in recurrent or metastatic head and neck squamous cell carcinoma. He is also an active member of ASCO, ESMO, and the Korean Cancer Study Group.
Connect with Bhumsuk Keam Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.